Duration of Hormone Replacement Therapy, Breast Tumour Size and Grade in a Screening Programme

By Gertig D.M.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 267-273

Springer Publishing Company

Access to resources Recommend Favorite

Use of Hormone Replacement Therapy and Adenocarcinomas and Squamous Cell Carcinomas of the Uterine Cervix

By Lacey J.V.   Brinton L.A.   Barnes W.A.   Gravitt P.E.   Greenberg M.D.   Hadjimichael O.C.   McGowan L.   Mortel R.   Schwartz P.E.   Kurman R.J.   Hildesheim A.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 149-154

Elsevier

Access to resources Recommend Favorite

Is a Dense Mammographic Parenchymal Pattern a Contraindication to Hormonal Replacement Therapy?

By Salminen Tiina M.   Saarenmaa Irma E.   Heikkilä Minna M.   Hakama Matti  

Acta Oncologica, Vol. 39, Iss. 8, 2000-11 ,pp. : 969-972

Informa Healthcare

Access to resources Recommend Favorite

Previous oral contraceptive use and breast cancer risk according to hormone replacement therapy use among postmenopausal women

By Dumeaux Vanessa  

Cancer Causes and Control, Vol. 16, Iss. 5, 2005-06 ,pp. : 537-544

Springer Publishing Company

Access to resources Recommend Favorite

Impact of postoperative hormone replacement therapy on life quality and prognosis in patients with ovarian malignancy

By                  

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 244-249

Spandidos Publications

Access to resources Recommend Favorite